Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial
NCT ID: NCT06324825
Last Updated: 2024-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
144 participants
INTERVENTIONAL
2022-10-24
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Jianpi Huoxue Recipe in Treating Gastric Premalignant Lesion
NCT03823248
The Role of Intestinal Flora in the Pathogenesis of FD and the Intervention of Xiangsha Liujunzi
NCT04449887
Efficacy and Safety of Hizikia Fusiformis Extract in Subjects Showing Erosive Gastritis
NCT01689701
International Clinical Study of Zhizhu Kuanzhong Capsule
NCT03825692
Treatment of Atrophic Gastritis After HP Eradication With Modified Liujunzi Decoction Based on Syndrome Differentiation
NCT05388890
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fuzhegn Nizeng Formula
Fuzhegn Nizeng Decoction
Subjects taking prepared Fuzhegn Nizeng granules twice daily for 6 month.
Moluodan patient medicine
Moluodan granules
Subjects taking prepared Moluodan granules 9g twice daily for 6 month.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fuzhegn Nizeng Decoction
Subjects taking prepared Fuzhegn Nizeng granules twice daily for 6 month.
Moluodan granules
Subjects taking prepared Moluodan granules 9g twice daily for 6 month.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Helicobacter pylori negative.
* TCM syndrome is spleen-stomach deficiency with blood stasis and phelgm.
Exclusion Criteria
* Combined with malignant tumor.
* History of mental illness.
* Allergy to any components of the drug use in the study.
* Planning to pregnancy, or pregnant woman and lactating woman.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University First Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University First Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022CR64
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.